Skip to main content

Pharmaceutical Interventions for Hearing Loss (PIHL) Working Group

There are currently no FDA-approved pharmaceutical preventative measures or treatment options for hearing loss or tinnitus. However, several promising agents are on the horizon as possible treatments. The HCE has organized a working group known as the Pharmaceutical Interventions for Hearing Loss, or PIHL group, which is dedicated to advancing this field of medical research.

Bringing together experts from across the DoD, VA, academia, and industry, the PIHL group coordinates subjects matter experts to develop and disseminate:

  • Current and comprehensive understanding of the state of the science, including compilation of current research, ongoing clinical trials and new study results,
  • Evidence-based research methodology standards, and
  • Capability-based requirements for technology transition to the DoD.

The PIHL group disseminates information through newsletters, available for download below.

PIHL Newsletters

PIHL Research Guidance Documents

DoD HCE PIHL Supplement Publications


About Us

The Hearing Center of Excellence fosters and promotes the prevention, diagnosis, mitigation, treatment, rehabilitation and research of hearing loss and auditory injury. It supports the development, exchange and adoption of best practices, research, measures of effectiveness and clinical care guidelines to reduce the prevalence and cost of hearing loss and tinnitus among Warriors and Veterans. Read more

Hearing Health Challenge For Change

Take the challenge, pledge your commitment, and share your story in the prevention of hearing loss in America today.

The Hearing Center of Excellence is committed to promoting Hearing Loss Programs and Hearing Loss Prevention Initiatives across the DoD. Take the pledge to implement the Comprehensive Hearing Health Program (CHHP) at your local clinic and share with us how it's going for you!

Pledge on Facebook Pledge on Twitter
Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.